Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

43.240
-3.060-6.61%
Volume:6.03M
Turnover:264.15M
Market Cap:25.17B
PE:-9.65
High:45.220
Open:45.060
Low:42.820
Close:46.300
52wk High:80.900
52wk Low:29.980
Shares:582.00M
HK Float Shares:582.00M
Volume Ratio:1.67
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-1.36%
PB:5.87
PE(LYR):-9.65
PS:23.76

Loading ...

Insilico Medicine Cayman Topco - Expects H1 2026 Revenue of Usd102.5 Mln-usd106.5 Mln, up 272.7%-287.3% Y/Y

THOMSON REUTERS
·
Jul 09

Insilico Medicine Expects H1 2026 Net Profit of USD 33.5 Million-usd 39.5 Million

Reuters
·
Jul 09

Insilico Medicine Begins Phase 3 Trial of Lung Disease Drug; Shares Up 3%

MT Newswires Live
·
Jul 08

Movement Alert|Insilico Medicine Rises 5.16% in Regular Trading, First AI-Discovered Drug Rentosertib Enters Phase III Clinical Trial

Market Focus
·
Jul 08

Insilico Commences Phase 3 Trial for Rentosertib

Stock News
·
Jul 08

Insilico Medicine Initiates Phase III Trial of IPF Drug Rentosertib

Reuters
·
Jul 07

Insilico Initiates Phase Iii Clinical Trial for Rentosertib, Its Ai-empowered Tnik Inhibitor for Idiopathic Pulmonary Fibrosis

THOMSON REUTERS
·
Jul 07

Movement Alert|Insilico Medicine Falls 5.11% in Regular Trading, Takeda Deal Gains Fully Priced In Amid Continued Lock-Up Selling Pressure

Market Focus
·
Jul 07

INSILICO expands share capital by 0.53% through option exercises and award vesting

Bulletin Express
·
Jul 06

Insilico Medicine Files HKEX Next-day Disclosure Return, Share Capital Rises by 3,052,484 Shares

Reuters
·
Jul 06

Movement Alert|Insilico Medicine Falls 6.32% in Regular Trading, Post-Takeda Deal Selling Pressure Persists

Market Focus
·
Jul 03

PRESS Digest -wall Street Journal - July 2

Reuters
·
Jul 02

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco: Total Deal Value to Approximately $600 Mln

THOMSON REUTERS
·
Jul 02

Movement Alert|Insilico Medicine Rises 5.81% in Regular Trading, Strategic Collaboration with Takeda Worth Up to $600 Million

Market Focus
·
Jul 02

Insilico Medicine Announces Strategic Collaboration with Takeda for AI-Driven Drug Discovery

Stock News
·
Jul 02

Insilico Medicine and Takeda Sign AI-Driven Drug Discovery Deal Worth up to USD600 million

Bulletin Express
·
Jul 02

Insilico Medicine Cayman Announces Drug Discovery Collaboration with Takeda Worth up to $600 Million

Reuters
·
Jul 02

Insilico Medicine Cayman Topco - Takeda Granted Exclusive Worldwide Rights to Develop and Commercialize Collaboration Therapeutics

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco - Deal Value up to Usd600 Mln Including USD60 Mln in Upfront and Near-term Payments

THOMSON REUTERS
·
Jul 02